Evidence for a Selective Role of the δ-Opioid Agonist [8<i>R</i>-(4b<i>S</i>*,8aα,8aβ,12bβ)]7,10-Dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9<i>H</i>)-4,8-methanobenzofuro[3,2-e]pyrrolo[2,3-g]isoquinoline Hydrochloride (SB-235863) in Blocking Hyperalgesia Associated with Inflammatory and Neuropathic Pain Responses

1995, J Pharmacol Exp Ther, 273, 359

2001, J Pharmacol Exp Ther, 296, 939

1997, J Pharmacol Exp Ther, 280, 1176

10.1016/S0304-3959(02)00333-0

10.1016/0006-2952(73)90196-2

10.1016/0304-3959(94)00275-J

2000, Diabetes Care, 23, 510, 10.2337/diacare.23.4.510

10.1006/abio.1999.4295

10.1016/0006-8993(91)91523-4

10.1038/sj.bjp.0703248

10.1016/0304-3959(92)90259-E

10.1016/S0304-3959(97)00221-2

10.1016/0304-3959(88)90026-7

1998, J Pharmacol Exp Ther, 285, 1181

1998, Analgesia, 3, 269, 10.3727/107156998819565947

2001, J Pharmacol Exp Ther, 298, 257

10.1016/S0014-2999(97)00085-X

1999, Pain, 75, 115

1995, J Neurosci, 15, 737, 10.1523/JNEUROSCI.15-01-00737.1995

1998, J Neurosci, 18, 7285, 10.1523/JNEUROSCI.18-18-07285.1998

1998, Chem Pharm Bull (Tokyo), 46, 1695, 10.1248/cpb.46.1695

1993, J Pharmacol Exp Ther, 265, 1245

10.1016/S0306-4522(98)00251-6

10.1016/S0304-3959(02)00320-2

10.1016/0014-2999(89)90061-7

10.1016/0165-6147(89)90267-8

10.1093/brain/119.2.347

1990, J Biol Chem, 265, 15176, 10.1016/S0021-9258(18)77238-4

10.1016/0304-3959(90)91074-S

1998, J Pharmacol Exp Ther, 287, 815

10.1016/0014-2999(92)90278-C

1988, J Pharmacol Exp Ther, 245, 587

10.1016/0006-8993(90)91297-T

1990, J Pharmacol Exp Ther, 254, 91

1997, J Pharmacol Exp Ther, 280, 600

10.1016/0006-8993(82)91029-0

10.1038/sj.bjp.0701330

1994, J Pharmacol Exp Ther, 338, 217

1998, J Pharmacol Exp Ther, 286, 1000